SCHEMBL24834879

SCHEMBL24834879

BC1(B)C(B)(B)C(B)(B)C(B)(c2ccc(-c3cc(=O)n4nc(-c5nccnc5C)c(C(=O)OCC)c4[nH]3)cc2)C(B)(B)C1(B)B

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 4/20 0.37
MAPT P10636 5/20 0.33
ALDH1A1 P00352 3/20 0.33
GCGR P47871 2/20 0.33
PKM P14618 1/20 0.33
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ADORA3 P0DMS8 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAT2A P31153 1/20 0.32
HTT P42858 2/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24834866 0.89
SCHEMBL24835445 0.83 PLAT (0.38) PLATMAPTALDH1A1GCGRPKM
SCHEMBL24834843 0.82
SCHEMBL24835012 0.82 PLAT (0.44) PLATMAPTALDH1A1GCGRPKM
SCHEMBL24834840 0.77 PLAT (0.40) PLATMAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL23415008 0.77 PLAT (0.39) PLATMAPTALDH1A1KDM4EMEN1
SCHEMBL24835002 0.77 PLAT (0.39) PLATMAPTALDH1A1KDM4EMEN1
SCHEMBL29785667 0.77 PLAT (0.39) PLATMAPTALDH1A1KDM4EMEN1
SCHEMBL24835003 0.77 PLAT (0.39) PLATMAPTALDH1A1KDM4EMEN1
SCHEMBL30172844 0.77 PLAT (0.39) PLATMAPTALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002396-A1 THERAPEUTIC COMPOUNDS GENENTECH, INC. (US) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002396-A1 THERAPEUTIC COMPOUNDS YAP1, YES1, TEAD2 PLAT 3745/4885MAPT 870/4885ALDH1A1 3527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.